GENERIC NAME: METHYLTESTOSTERONE W/ESTROGEN - ORAL (METH-ill-tess-TOSS-ter-own WITH ESS-trow-jen)
BRAND NAME(S): Estratest, Menogen, Premarin w/Methyltestosterone
Warning | Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage
WARNING: This drug has been reported to increase the chance of womb (endometrial) cancer in women who have been through menopause. It also may increase the risk of cancer of the ovary or breast. Therefore, use of estrogen-only hormone therapy (e.g., in women without a uterus) must be cautious. These risks of treatment appear to depend on the length of time this drug is used and the amount of estrogen per dose. Consult your doctor or pharmacist for details. If you use this drug for an extended period, you should be evaluated at least every year. If you experience abnormal vaginal bleeding or lumps in the breast, notify your doctor promptly. This medication is not effective in preventing or treating a tendency toward miscarriages (natural habitual abortion) nor the threat of miscarriage. This drug must not be used during pregnancy because its use may result in birth defects or cancer later in the child's life. If you become pregnant or think you may be pregnant, consult your doctor immediately to discuss the risk to the fetus.
USES: This medication is a combination of hormones used to treat symptoms of menopause when estrogens alone are not effective. Estrogen-containing products should not be used to prevent heart disease.
HOW TO USE: This medication is taken by mouth usually once a day for 21 days, followed by no medication for 7 days, or take as directed by your doctor. Follow the dosing schedule carefully. This drug should be used for the shortest possible length of time. Consult your doctor or pharmacist if you have any questions. Do not increase your dose, take this more often than directed or stop taking this medication without first consulting your doctor.
 |
 |
From the Doctors at MedicineNet.com  |
 |
Back to Medications IndexLast Editorial Review: 3/2/2005